Warner Lambert

For profitContributed to NME

Also known as: Warner-Lambert | Warner Lambert - Parke Davis

Phase 1 Phase 2 Phase 3 Phase 4

First clinical trial

Nov 2, 1999

First marketed drug

Dec 6, 1972

First NDA

Dec 30, 1993

Last known activity

Nov 2, 1999

Acquired by Pfizer on Jan 1, 2000

Timeline

1950s

Jan 1, 1955
Warner Lambert— Founded
Jan 1, 1955
Lambert— Acquired
Jan 1, 1955
Warner— Acquired
Jun 1, 1957
Nepera Chemical Company— Acquired

1960s

Jan 1, 1966
Texas Pharmacal— Acquired

1970s

Dec 31, 1970
Parke-Davis— Acquired

1980s

Jul 17, 1981
atropine— Marketing Organization

1990s

Jan 1, 1993
Wilkinson Sword— Acquired
Dec 30, 1993
gabapentin— NDA Organization
Apr 26, 1996
quinestrol— NDA Secondary Org
Jan 1, 1999
Agouron— Acquired

2000s

Jan 1, 2000
Pfizer— Acquired By

Drugs by trial phase (33 distinct, 30 trials)

Phase 4 (0 own, 10 via acquisition)

Phase 3 (0 own, 12 via acquisition)

Phase 2 (0 own, 4 via acquisition)

Phase 1 (0 own, 1 via acquisition)

ci-1012

Other trials (1 own, 5 via acquisition)

Indications

Approved for

Subsidiaries (7 direct, 7 total across the full acquisition tree)

Recent trials (1)

NCT00000955CollaboratorN/ANov 2, 1999

Details

Founded: Morris Plains, NJ, US Jan 1, 1955
First NDA: Dec 30, 1993
Last known activity: Nov 2, 1999

Designations held

Priority review